„Revolutionäre“ kühlschrankfreie Impfstoffe, die in Großbritannien getestet werden sollen

British scientists have begun the world’s first clinical trial of a vaccine that doesn’t require refrigeration, using breakthrough technology that could become a „global lifesaver.“ Currently, most vaccines must be kept cold or frozen, and this „cold chain“ poses a major obstacle to vaccinating people in developing nations — resulting in around half of all vaccines being discarded each year.